November 6, 2019 by Chain Drug Review
KKR, Walgreens
Business, Leading Headlines, Retail News

NEW YORK — According to various published reports, Walgreens Boots Alliance is exploring going private in what could mark the largest leveraged buyout in history. One of the firms looking at a deal is KKR. KKR has a history with the retailer. In 2007, it bought Alliance Boots in partnership with Stefano Pessina, then the
December 7, 2017 by Chain Drug Review
Alex Gourlay, Gregory Weishar, Jim Momtazee, KKR, Kohlberg Kravis Roberts, PharMerica, Walgreens Boots Alliance
Business, Leading Headlines, Pharmacy, Retail News

LOUISVILLE, Ky. — Walgreens Boots Alliance (WBA) is now a stakeholder in national specialty pharmacy operator PharMerica Corp. PharMerica on Wednesday announced the close of its acquisition by global investment firm Kohlberg Kravis Roberts (KKR). Under the $1.4 billion deal, unveiled in early August, WBA holds a minority share in PharMerica. Louisville, Ky.-based PharMerica serves
September 28, 2017 by Chain Drug Review
Kellogg, KKR, Nate Taylor, Nature's Bounty, Paul Sturman, Steve Cahillane, The Carlyle Group
Business, Leading Headlines, Supplier News

NEW YORK — Steve Cahillane, president and chief executive officer of The Nature’s Bounty Co., is leaving the company to become chairman and CEO of Kellogg Co. Kellogg said Thursday that Cahillane is slated to take the CEO reins of the global cereal and snack company and join its board of directors on Oct. 2. He
July 24, 2017 by Chain Drug Review
KKR, Steve Cahillane, The Carlyle Group, The Nature’s Bounty Co.
Supplier News

NEW YORK – The investment firm KKR has agreed to become the majority owner of The Nature’s Bounty Co., a wellness products company known for such brands as Nature’s Bounty, Sundown Naturals and Osteo Bi-Flex. The Carlyle Group, the company’s current owner, will retain a significant stake in the company. The deal is expected to
November 2, 2016 by Chain Drug Review
Alliance Boots merger, Barry Rosenstein, Dominic Murphy, JANA Partners, KKR, Kohlberg Kravis Roberts, Stefano Pessina, Walgreens Boots Alliance, WBA board of directors
Business, Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill. — Affiliates of private equity firm Kohlberg Kravis Roberts & Co. (KKR) plan to sell their remaining interest in Walgreens Boots Alliance (WBA) through a secondary stock offering. WBA said Wednesday that the KKR affiliates aim to sell 20.46 million shares of WBA common stock in an underwritten secondary offering. And in a
May 23, 2016 by Chain Drug Review
Barry Rosenstein, Dominic Murphy, James Skinner, JANA Partners, KKR, Kohlberg Kravis Roberts, Stefano Pessina, Walgreens Boots Alliance, WBA
Business, Leading Headlines, Retail News

DEERFIELD, Ill. — Activist investor Barry Rosenstein, managing partner of hedge fund JANA Partners LLC, has stepped down from the Walgreens Boots Alliance (WBA) Inc. board after reducing his investment in the company. WBA said late Friday that Rosenstein, who has been a director since September 2014, was slated to end his service on the
January 5, 2015 by Chain Drug Review
Alliance Boots, Dominic Murphy, Greg Wasson, Jim Skinner, KKR, merger, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens shareholders, WBA
Business, Featured Articles, Retail News

DEERFIELD, Ill. – As expected, Walgreen Co. and Alliance Boots GmbH have finalized the second step of their two-part merger agreement following Walgreens shareholders’ approval earlier this week. Coming just before the new year, the completion of the deal announced in 2012 reorganizes Walgreens into a subsidiary of a new holding company, Walgreens Boots Alliance